Statin Therapy

• 2019 ACA/AHA Guidelines

• Curbsiders 2020 Review

• Discontinuing statins in the elderly: There may be marginal benefit for ages 70-85 years and harms may outweigh risks in patients age 85 years or olders

2013 Guidelines

Age ≥ 40 years with

• No risk factor and ASCVD

  • < 7.5% → No statin

  • ≥ 7.5% → Moderate intensity statin

• Diabetes mellitus

  • < 7.5% → Moderate intensity statin

  • ≥ 7.5% → High intensity statin

• Atherosclerotic disease with age

  • > 75 years → Moderate intensity statin

  • ≤ 75 years → High intensity statin

• LDL ≥ 190 → High intensity statin